About EUFEMED webinar: Preferences of Phase I participants

We live in rapidly changing times. Do we still know the expectations and preferences of our healthy trial participants? Do we know about their reasons for joining a trial and the information they would like to get before and after their participation? Do we know about their interest in supporting the research team from their perspective as a participant?

To better understand the situation today, EUFEMED has performed a European survey and received 4349 evaluable responses from Belgium, France, Netherlands, Germany, Hungary, United Kingdom and other countries. 

In this webinar we will present the results. Please join us in discussing the findings and their impact.  

Agenda

• 16:00 - Welcome, Introduction, Moderation by Ingrid Klingmann, EUFEMED, Pharmaplex
• 16:05 - Content, dissemination and returns of the Survey by Dick de Vries
• 16:20 - Results: Reasons for participation and needs during the trial by Thijs Van Iersel, ICON + Discussion
• 16:55 - Results: Expectations for additional information and contribution options as well as participants’ attitude towards risks in the trial by Jelle Klein, SGS, EUFEMED + Discussion
• 17:30 - End of the webinar

__________________________________________________________________________

This is the last of four 2023-2024 EUFEMED webinars. 

Member tickets are available for members of: Association of Human Pharmacology in the Pharmaceutical Industry (AHPPI - UK), Healixia (Belgium), Association Française de Pharmacologie Translationnelle (AFPT – France), Association for Applied Human Pharmacology (AGAH - Germany), Associatie van Contract Research Organisaties in Nederland (ACRON - Netherlands), and Polish Federation for Early Medicines Development (Polfemed - Poland)